This week addressed AI accountability, CPHI award winners, NFC anticounterfeiting, first-in-class FDA approvals, and a shelved FDA voucher pilot lead this week’s roundup.
|Articles|February 1, 2003
- Pharmaceutical Technology-02-01-2003
- Volume 2003 Supplement
- Issue 1
Challenges, Considerations, and Benefits of Raw Materials Testing
Author(s)Gregory D. Kupp
Raw materials testing ensures that the raw materials used in pharmaceutical products are suitable for their intended use. Conducting raw materials analysis using appropriate test methods and successfully meeting the challenges of such testing can prevent costly production problems and delays.
Advertisement
Articles in this issue
almost 24 years ago
Implementing Successful Stability Testing Operationsalmost 24 years ago
Choosing a Contract Research Organization for Analytical TestingAdvertisement
Related to this article
Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.
Gloveless isolators don’t end interventions. Learn to assess intervention dependency in robotic aseptic filling and when glove ports are justified.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
The FDA has shelved its National Priority Voucher pilot, leaving sponsors that built CMC and launch-readiness plans around 1- to 2-month reviews facing uncertain timelines.
Regulators will test pharma companies against their own internal AI policies. Jaenisch, Muraru, and Pandey explain how to build defensible, inspection-ready AI practices.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI Pharma Award Winner: Drug Delivery, Devices, & Packaging
2
Manufacturing Intelligence: AI Poisoning Demands Pharma Data Stewards
3
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
4
Investing in Protecting Pharma Products
5